Association of tumor necrosis factor-α-308 (G→A) polymorphism and susceptibility to brucellosis

Journal of Microbiology, Immunology and Infection

Volumn 42, Issue 1, 2009, Pages 22-26

  Reza, Jafari Shakib ^a   Alireza, Rafiei ^b   Mostafa, Ansari ^c   Alireza, Khalilian ^c   Mehrdad, Hajilooi ^d  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b MAZANDARAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d HAMADAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Brucellosis; Genetic; Polymorphism; Tumor necrosis factor alpha

Indexed keywords

DNA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BRUCELLOSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; DNA EXTRACTION; FEMALE; GENOTYPE; HOMOZYGOTE; HUMAN; HUMAN CELL; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PROTEIN POLYMORPHISM;

BRUCELLOSIS; CHI-SQUARE DISTRIBUTION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LOGISTIC MODELS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 67549094813     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Cutler SJ, Whatmore AM, Commander NJ. Brucellosis - new aspects of an old disease. J Appl Microbiol. 2005;98: 1270-81.
2. Godfroid J, Cloeckaert A, Liautard JP, Kohler S, Fretin D, Walravens K, et al. From the discovery of the Malta fever's agent to the discovery of a marine mammal reservoir, brucellosis has continuously been a re-emerging zoonosis. Vet Res. 2005;36:313-26.
3. Pappas G, Akritidis N, Bosilkovski M, Tsianos E. Brucellosis. N Engl J Med. 2005;352:2325-36.
4. Bidwell J, Keen L, Gallagher G, Kimberly R, Huizinga T, McDermott MF, et al. Cytokine gene polymorphism in human disease: on-line databases. Genes Immun. 1999;1: 3-19.
5. Keen LJ. The extent and analysis of cytokine and cytokine receptor gene polymorphism. Transpl Immunol. 2002; 10:143-6.
6. Zhan Y, Liu Z, Cheers C. Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun. 1996;64:2782-6.
7. Yingst S, Hoover DL. T cell immunity to brucellosis. Crit Rev Microbiol. 2003;29:313-31.
8. Baldwin CL, Parent M. Fundamentals of host immune response against Brucella abortus: what the mouse model has revealed about control of infection. Vet Microbiol. 2002;90:367-82.
9. Caballero A, Bravo MJ, Nieto A, Colmenero JD, Alonso A, Martin J. TNFA promoter polymorphism and susceptibility to brucellosis. Clin Exp Immunol. 2000;121:480-3.
10. Demirdag K, Ozden M, Kalkan A, Godekmerdan A, Sirri Kilic S. Serum cytokine levels in patients with acute brucellosis and their relation to the traditional inflammatory markers. FEMS Immunol Med Microbiol. 2003;39:149-53.
11. Ahmed K, Al-Matrouk KA, Martinez G, Oishi K, Rotimi VO, Nagatake T. Increased serum levels of interferon- gamma and interleukin-12 during human brucellosis. Am J Trop Med Hyg. 1999;61:425-7.
12. Refik M, Mehmet N, Durmaz R, Ersoy Y. Cytokine profile and nitric oxide levels in sera from patients with brucellosis. Braz J Med Biol Res. 2004;37:1659-63.
13. Hajeer AH, Hutchinson IV. TNF-alpha gene polymorphism: clinical and biological implications. Microsc Res Tech. 2000; 50:216-28.
14. Mazaheri S, Hajilooi M. Rafiei A. The G-308A promoter variant of the tumor necrosis factor-alpha gene is associated with migraine without aura. J Neurol. 2006;253: 1589-93.
15. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf- Lafontaine N, Roland S, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol. 1998;113: 401-6.
16. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA. 1997;94:3195-9.
17. Nakane A, Minagawa T, Kato K. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect Immun. 1988;56: 2563-9.
18. Jo EK, Park JK, Dockrell HM. Dynamics of cytokine generation in patients with active pulmonary tuberculosis. Cur Opin Infect Dis. 2003;16:205-10.
19. Caron E, Gross A, Liautard JP, Dornand J. Brucella species release a specific, protease-sensitive, inhibitor of TNF- alpha expression, active on human macrophage-like cells. J Immunol. 1996;156:2885-93.
20. Jubier-Maurin V, Boigegrain RA, Cloeckaert A, Gross A, Alvarez-Martinez MT, Terraza A, et al. Major outer membrane protein Omp25 of Brucella suis is involved in inhibition of tumor necrosis factor alpha production during infection of human macrophages. Infect Immun. 2001;69:4823-30.
21. Wilhelm P, Ritter U, Labbow S, Donhauser N, Röllinghoff M, Bogdan C, et al. Rapidly fatal leishmaniasis in resistant C57BL/6 mice lacking TNF. J Immunol. 2001;166:4012-9.
22. Bacellar O, Lessa H, Schriefer A, Machado P, Ribeiro de Jesus A, Dutra WO, et al. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect Immun. 2002;70:6734-40.
23. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 1994;371:508-10.
24. Roy S, McGuire W, Mascie-Taylor CG, Saha B, Hazra SK, Hill AV, et al. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis. 1997;176:530-2.
25. Cabrera M, Shaw MA, Sharples C, Williams H, Castes M, Convit J, et al. Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishmaniasis. J Exp Med. 1995;182:1259-64.
26. Nadel S, Newport MJ, Booy R, Levin M. Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis. 1996;174:878-80.
27. Davoudi S, Amirzargar AA, Hajiabdolbaghi M, Rasooline- jad M, Soodbakhsh A, Jafari S, et al. Th-1 cytokines gene polymorphism in human brucellosis. Int J Immunogenet. 2006;33:355-9.
28. Budak F, Göral G, Heper Y, Yilmaz E, Aymak F, Baştürk B, et al. IL-10 and IL-6 gene polymorphisms as potential host susceptibility factors in brucellosis. Cytokine. 2007;38: 32-6.